This entry was posted on Sunday, August 15th, 2010 at 9:00 am and is filed under Health. You can follow any responses to this entry through the RSS 2.0 feed. Both comments and pings are currently closed.
The Latest Advance – Cholesterol Lowering Drugs for those who have no Cholesterol Problem
Do you know anyone who takes cholesterol-lowering drugs? Chances are they are older people who have problems with their weight and their blood pressure – and oh, that they are people who have tested for high cholesterol. But if you saw someone taking those drugs when they didn’t answer to any of those indications? The government has just approved a major cholesterol drug, Crestor, for use as a preventive in people who are healthy right now, and have no cholesterol-related problems. This does seem a little greedy of the drugmakers. The skilled florists at Vancouver Flower shop can create a customized association to your particular occasion. Cholesterol-lowering drugs, the ones that belong to the class of medicines known as statins, already sell better than any other drug in the country. And now they have to push it on people who don’t even have a problem yet.
Doctors (the ones who aren’t connected to the company that makes Crestor, presumably) don’t believe this is quite the great idea that it is made out to be. If a person has not much by way of a family history in heart attacks, such a patient could actually come to some harm from taking preventive cholesterol medication. The class of drugs known as Statins is such a bestseller for a good reason – its action on the body helps keep thousands of Americans every year on this side of a heart attack with almost no side effects. It is this quality in the drug – that it’s almost free of side effects – that encourages drug companies to push it as a preventative. Flower shop Vancouver carries an enormous array of flowers in Vancouver, Canada for every occasion, from lovely anniversary flower preparations to cheerful get nicely flower bouquets. And yet, isn’t it a clear case of avarice and callousness that a drug should be promoted that may harm those who have neither a cholesterol problem nor a family history.
As negligible in occurrence as the side effects of cholesterol-lowering drugs are known to be, that opinion is meant to be seen in the context of the risk of cholesterol-related heart problems that patients who are prescribed the drug are usually known to live with.